Screening compound: InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2

Screening compound: InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2
Screening compound: InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T813-0101

Molecular Formula

C21H23N3O (C21 H23 N3 O)

Compound Name

1-benzyl-4-[(5-phenyl-1,2-oxazol-4-yl)methyl]piperazine

IUPAC name

1-benzyl-4-[(5-phenyl-12-oxazol-4-yl)methyl]piperazine

SMILES

C(c1c(-c2ccccc2)onc1)N1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2

InChI Key

UIPQZZOEOTZPTK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27623695

InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

SmartTM Library (51161 compounds)

Ion Channels Focused Library (26372 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Ion Channels
  • Phosphatases

References: we are preparing a list of scientific research reports with InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2?
Check Price and Availability of InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H23N3O/c1-3-7-18(8-4-1)16-23-11-13-24(14-12-23)17-20-15-22-25-21(20)19-9-5-2-6-10-19/h1-10,15H,11-14,16-17H2 available by request